Abstract:Development of small-sized nanoformulations for effective tumor penetration, particularly for those tumors with dense stroma is a major challenge in cancer nanomedicine. It is even more challenging to achieve effective co-loading of both hydrophobic and hydrophilic anticancer agents through a small-sized nanocarrier. In this work, we designed a novel redox-responsive gemcitabine (GEM)-conjugated polymer POEG-co-PVDGEM (PGEM) as a small-sized nanocarrier to co-deliver hydrophilic GEM and hydrophobic paclitaxel (PTX). Methods: The in vitro physicochemical and biological properties of PTX/PGEM NPs were characterized. The efficiency of the PGEM carrier in selective codelivery of GEM and PTX in two murine tumor models as well as a patient derived xenograft model (PDX) was also evaluated. In addition, we investigated the changes in tumor immune microenvironment after treatment with PTX/PGEM nanoparticles. Results: We discovered that GEM conjugation could significantly decrease the nanoparticle size from 160 nm to 13 nm. Moreover, different from most reported GEM-conjugated polymers, PGEM polymer could serve as a prodrug carrier to load a wide variety of hydrophobic agents with high drug loading capacity and excellent stability. More importantly, our strategy could be extended to various nucleotides-based drugs such as azacytidine, decitabine and cytarabine, suggesting a new platform for co-delivery of various first line hydrophilic and hydrophobic anticancer agents. Imaging showed that our small-sized carrier was much more effective in tumor accumulation and penetration compared to the relatively large-sized drug carrier. The PGEM prodrug-based carrier not only well retained the pharmacological activity of GEM, but also boosted T-cell immune response. Furthermore, delivery of PTX via PGEM led to significantly improved antitumor activity in several murine cancer models and a PDX model of colon cancer. Conclusion: This work not only provided a small-sized carrier platform that was able to load multiple hydrophilic and hydrophobic drugs with high loading capacity, but also provided an effective regimen for enhanced tumor penetration and improved anti-tumor immunity.

Research on GGT-responsive Drug Carrier with Active Transport Effect

Enzyme-triggered transcytosis of drug carrier system for deep penetration into hepatoma tumors

Active Transportation of Liposome Enhances Tumor Accumulation, Penetration, and Therapeutic Efficacy

A γ-Glutamyl Transpeptidase (GGT)-Triggered Charge Reversal Drug-Delivery System for Cervical Cancer Treatment: In Vitro and In Vivo Investigation

Hydrophobicity Effects of γ-Glutamyl Transpeptidase-Responsive Polymers on the Catalytic Activity and Transcytosis Efficacy

Microenvironment-responsive Chemotherapeutic Nanogels for Enhancing Tumor Therapy Via DNA Damage and Glutathione Consumption

Poly-γ-glutamic Acid Derived Nanopolyplexes for Up-Regulation of Gamma-Glutamyl Transpeptidase to Augment Tumor Active Targeting and Enhance Synergistic Antitumor Therapy by Regulating Intracellular Redox Homeostasis

Research Progress in Construction of Organic Carrier Drug Delivery Platform Using Tumor Microenvironment

Research Progress of Tumor Microenvironment-responsive Anti-tumor Nano-drug Carriers

Evaluation of <i>in Vitro</i> Tumor Penetration Behavior of Enzyme-responsive Dendrimer-drug Conjugate

A Rapid Dual-Responsive Releasing Nano-Carrier by Decomposing the Copolymer and Reversing the Core Dissolution

Tumor-microenvironment responsive nano-carrier system for therapy of prostate cancer

“Stealth and Fully-Laden” Drug Carriers: Self-Assembled Nanogels Encapsulated with Epigallocatechin Gallate and Sirna for Drug-Resistant Breast Cancer Therapy

High Loading of Hydrophobic and Hydrophilic Agents Via Small Immunostimulatory Carrier for Enhanced Tumor Penetration and Combinational Therapy

A Nanogel with Effective Blood-Brain Barrier Penetration Ability through Passive and Active Dual-Targeting Function

Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery.

Precise delivery of multi-stimulus-responsive nanocarriers based on interchangeable visual guidance

Tacmaa Chemistry-Based Tumor Extracellular Ph-Responsive Polymeric Nanomaterials For Drug Delivery

Enhancing cancer chemo-immunotherapy by biomimetic nanogel with tumor targeting capacity and rapid drug-releasing in tumor microenvironment

Delivery process and effective design of vectors for cancer therapy